Table 2.
Indications for referral to the SIC
| Referral Indication | Number (%) N = 171 | |
|---|---|---|
| Vaccine Hesitancy | 48 | (28%) |
| - attended* | 38 | (22.2%) |
| - excluded** | 5 | (2.9%) |
| - did not attend | 5 | (2.9%) |
| Prior Adverse Event Following Immunisation | 84 | (49%) |
| - attended | 83 | (48.5%) |
| - did not attend | 1 | (0.6%) |
| Pre or Post-Transplant or Post-Chemotherapy | 19 | (11.1%) |
| - attended | 17 | (9.9%) |
| - did not attend | 2 | (1.2%) |
| Immigration to Australia for Catch Up Vaccination | 8 | (4.5%) |
| - attended | 7 | (4.1%) |
| - did not attend | 1 | (0.6%) |
| Allergic to Egg | 3 | (1.8%) |
| Vaccination Allergy | 3 | (1.8%) |
| Requesting Sedation (Intellectual Disability/Needlephobia) | 3 | (1.8%) |
| Hepatitis B Non-Responder | 2 | (1.2%) |
| Asplenia | 1 | (1.6%) |
| Total Non-Attending | 9 | (5.3%) |
| Total Attending | 162 | (94.7%) |
*
All included in the study.
**
Two children were excluded because they were siblings of an included child and 3 were excluded due to comorbid complex medical condition (2 with complex seizure disorders and one baby antenatally exposed to maternal immunomodulating antibody therapy).